BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24681958)

  • 1. High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma.
    Kuo PY; Leshchenko VV; Fazzari MJ; Perumal D; Gellen T; He T; Iqbal J; Baumgartner-Wennerholm S; Nygren L; Zhang F; Zhang W; Suh KS; Goy A; Yang DT; Chan WC; Kahl BS; Verma AK; Gascoyne RD; Kimby E; Sander B; Ye BH; Melnick AM; Parekh S
    Oncogene; 2015 Mar; 34(10):1231-40. PubMed ID: 24681958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma.
    Wang X; Björklund S; Wasik AM; Grandien A; Andersson P; Kimby E; Dahlman-Wright K; Zhao C; Christensson B; Sander B
    PLoS One; 2010 Nov; 5(11):e14085. PubMed ID: 21124928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma.
    Emruli VK; Olsson R; Ek F; Ek S
    BMC Cancer; 2016 Jul; 16():493. PubMed ID: 27430213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-132-3p serves as a tumor suppressor in mantle cell lymphoma via directly targeting SOX11.
    Wu B; Li J; Wang H; Wu Q; Liu H
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2197-2208. PubMed ID: 32040593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expression.
    Wasik AM; Lord M; Wang X; Zong F; Andersson P; Kimby E; Christensson B; Karimi M; Sander B
    Sci Rep; 2013; 3():1400. PubMed ID: 23466598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma.
    Mohanty A; Sandoval N; Phan A; Nguyen TV; Chen RW; Budde E; Mei M; Popplewell L; Pham LV; Kwak LW; Weisenburger DD; Rosen ST; Chan WC; Müschen M; Ngo VN
    Blood; 2019 Jan; 133(4):306-318. PubMed ID: 30530749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX11 augments BCR signaling to drive MCL-like tumor development.
    Kuo PY; Jatiani SS; Rahman AH; Edwards D; Jiang Z; Ahr K; Perumal D; Leshchenko VV; Brody J; Shaknovich R; Ye BH; Parekh S
    Blood; 2018 May; 131(20):2247-2255. PubMed ID: 29615403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma.
    Balsas P; Palomero J; Eguileor Á; Rodríguez ML; Vegliante MC; Planas-Rigol E; Sureda-Gómez M; Cid MC; Campo E; Amador V
    Blood; 2017 Jul; 130(4):501-513. PubMed ID: 28533307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma.
    Vegliante MC; Palomero J; Pérez-Galán P; Roué G; Castellano G; Navarro A; Clot G; Moros A; Suárez-Cisneros H; Beà S; Hernández L; Enjuanes A; Jares P; Villamor N; Colomer D; Martín-Subero JI; Campo E; Amador V
    Blood; 2013 Mar; 121(12):2175-85. PubMed ID: 23321250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX11, a key oncogenic factor in mantle cell lymphoma.
    Beekman R; Amador V; Campo E
    Curr Opin Hematol; 2018 Jul; 25(4):299-306. PubMed ID: 29738333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma.
    Jing C; Zheng Y; Feng Y; Cao X; Xu C
    Sci Rep; 2021 Jun; 11(1):11896. PubMed ID: 34099776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX11 regulates the pro-apoptosis signal pathway and predicts a favorable prognosis of mantle cell lymphoma.
    Yang W; Wang Y; Yu Z; Li Z; An G; Liu W; Lv R; Ma L; Yi S; Qiu L
    Int J Hematol; 2017 Aug; 106(2):212-220. PubMed ID: 28429312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of SOX11 mRNA in mantle cell lymphoma and its clinical significance].
    Wang YY; Yu Z; Yi SH; Li ZJ; Li CH; Xie ZQ; Li F; Zang MR; Hao M; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):556-60. PubMed ID: 22967417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma.
    Palomero J; Vegliante MC; Rodríguez ML; Eguileor A; Castellano G; Planas-Rigol E; Jares P; Ribera-Cortada I; Cid MC; Campo E; Amador V
    Blood; 2014 Oct; 124(14):2235-47. PubMed ID: 25092176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.
    Zhou K; Feng X; Wang Y; Liu Y; Tian L; Zuo W; Yi S; Wei X; Song Y; Qiu L
    Exp Hematol; 2018 Feb; 58():27-34.e1. PubMed ID: 29158064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX11 and HIG-2 are cross-regulated and affect growth in mantle cell lymphoma.
    Kuci V; Nordström L; Conrotto P; Ek S
    Leuk Lymphoma; 2016 Aug; 57(8):1883-92. PubMed ID: 26757780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX11 expression in mantle cell lymphoma.
    Xu W; Li JY
    Leuk Lymphoma; 2010 Nov; 51(11):1962-7. PubMed ID: 20919851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma.
    De Bolòs A; Sureda-Gómez M; Carreras-Caballé M; Rodríguez ML; Clot G; Beà S; Giné E; Campo E; Balsas P; Amador V
    Sci Rep; 2024 Apr; 14(1):7863. PubMed ID: 38570586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knock-down of SOX11 induces autotaxin-dependent increase in proliferation in vitro and more aggressive tumors in vivo.
    Conrotto P; Andréasson U; Kuci V; Borrebaeck CA; Ek S
    Mol Oncol; 2011 Dec; 5(6):527-37. PubMed ID: 21880559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship of Expression Between SOX11 and PAX5 in Pathological Tissue Specimens of Patients with Mantle Cell Lymphoma and Its Clinical Significance].
    Jing CX; Feng Y; Cao X; Xu CG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):355-360. PubMed ID: 32543142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.